INS and Insulin resistance: A ~50% reduction in the homeostatic model of assessment for insulin resistance (HOMA‐IR) with FA supplementation at both 5× and 10× doses was previously reported in our cohort [12], indicating improved systemic insulin sensitivity, which primarily reflects hepatic insulin action under fasting conditions [34].